Citation 88239

KOORBANALLY,NA: RANDRIANARIVELOJOSIA,M: MULHOLLAND,DAQUARLES VAN RFFORD,L:. (2002). BIOACTIVE CONSTITUENTS OF CEDRELOPSIS MICROFOLIATA.. 65(9)

Citation Details

Title	BIOACTIVE CONSTITUENTS OF CEDRELOPSIS MICROFOLIATA.
Authors	KOORBANALLY,NA: RANDRIANARIVELOJOSIA,M: MULHOLLAND,DAQUARLES VAN RFFORD,L:
Year	2002
Volume	65
Issue	9

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Cedrelopsis microfoliolata (MELIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MICROFOLIAN	None
2	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROFOLIAN	ACTIVE
3	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROFOLIAN	ACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MICROFOLIONE	None
5	ESTROGEN RECEPTOR(ALPHA) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROFOLIONE	ACTIVE
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MICROFOLICOUMARIN	None
7	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	SESQUICHAMAENOL,(-):	None
8	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTED	AGRANDOL	None
9	ESTROGEN RECEPTOR(ALPHA) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AGRANDOL	ACTIVE
10	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGRANDOL	ACTIVE
11	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AGRANDOL	ACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTED	CEDRECOUMARIN A	None
13	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTED	OBLIQUIN	None
14	ESTROGEN RECEPTOR(ALPHA) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OBLIQUIN	ACTIVE
15	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OBLIQUIN	ACTIVE
16	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OBLIQUIN	ACTIVE

Show SPARQL Queries (1)